|
|
 |
|
Holdings of the Fund as of 8/29/2025
Total Number of Holdings (excluding cash): 17
| US Dollar |
$USD |
|
21,977,594 |
$21,977,593.72 |
62.39% |
| Olo Inc. (Class A) |
OLO |
68134L109 |
155,702 |
$1,595,945.50 |
4.53% |
| SpartanNash Company |
SPTN |
847215100 |
59,346 |
$1,590,472.80 |
4.52% |
| Couchbase, Inc. |
BASE |
22207T101 |
64,994 |
$1,585,203.66 |
4.50% |
| Skechers U.S.A., Inc. |
SKX |
830566105 |
22,199 |
$1,400,312.92 |
3.98% |
| AvidXchange Holdings, Inc. |
AVDX |
05368X102 |
140,401 |
$1,395,585.94 |
3.96% |
| Informatica Inc. (Class A) |
INFA |
45674M101 |
50,015 |
$1,246,873.95 |
3.54% |
| GMS Inc. |
GMS |
36251C103 |
11,193 |
$1,230,446.49 |
3.49% |
| Kellanova |
K |
487836108 |
13,600 |
$1,081,200.00 |
3.07% |
| Frontier Communications Parent, Inc. |
FYBR |
35909D109 |
24,846 |
$921,289.68 |
2.62% |
| Surmodics, Inc. |
SRDX |
868873100 |
19,921 |
$678,110.84 |
1.93% |
| ProAssurance Corporation |
PRA |
74267C106 |
21,932 |
$522,200.92 |
1.48% |
| Bristol-Myers Squibb Co. - CVR |
2367655D |
|
39,856 |
$0.00 |
0.00% |
| Chinook Therapeutics Cvr |
.KDNYCVR |
169CVR016 |
43,869 |
$0.00 |
0.00% |
| Icosavax Inc Cvr |
.ICVXCVR |
451CVR021 |
100,745 |
$0.00 |
0.00% |
| Johnson & Johnson - CVR |
.JNJ-CVR |
003CVR016 |
7,137 |
$0.00 |
0.00% |
| Sycamore Partners Llc -Right |
2556706D |
931CVR013 |
76,307 |
$0.00 |
0.00% |
| Zimmer Biomet Holdings, Inc. (CVR) |
2544621D |
|
97,345 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|